IDYA
Price
$36.04
Change
-$0.99 (-2.67%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
3.25B
75 days until earnings call
Intraday BUY SELL Signals
IMTX
Price
$9.93
Change
+$0.10 (+1.02%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
1.32B
69 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IDYA vs IMTX

Header iconIDYA vs IMTX Comparison
Open Charts IDYA vs IMTXBanner chart's image
IDEAYA Biosciences
Price$36.04
Change-$0.99 (-2.67%)
Volume$8.41K
Capitalization3.25B
Immatics
Price$9.93
Change+$0.10 (+1.02%)
Volume$3.8K
Capitalization1.32B
IDYA vs IMTX Comparison Chart in %
IDYA
Daily Signal:
Gain/Loss:
IMTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IDYA vs. IMTX commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and IMTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (IDYA: $37.03 vs. IMTX: $9.83)
Brand notoriety: IDYA and IMTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 164% vs. IMTX: 69%
Market capitalization -- IDYA: $3.25B vs. IMTX: $1.32B
IDYA [@Biotechnology] is valued at $3.25B. IMTX’s [@Biotechnology] market capitalization is $1.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 1 FA rating(s) are green whileIMTX’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 1 green, 4 red.
  • IMTX’s FA Score: 0 green, 5 red.
According to our system of comparison, IDYA is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 4 TA indicator(s) are bullish while IMTX’s TA Score has 3 bullish TA indicator(s).

  • IDYA’s TA Score: 4 bullish, 4 bearish.
  • IMTX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than IMTX.

Price Growth

IDYA (@Biotechnology) experienced а -2.19% price change this week, while IMTX (@Biotechnology) price change was -0.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.44%. For the same industry, the average monthly price growth was +2.31%, and the average quarterly price growth was +42.34%.

Reported Earning Dates

IDYA is expected to report earnings on Mar 31, 2026.

IMTX is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (-0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($3.25B) has a higher market cap than IMTX($1.32B). IDYA YTD gains are higher at: 7.116 vs. IMTX (-6.381). IMTX has higher annual earnings (EBITDA): -106.34M vs. IDYA (-204.84M). IDYA has more cash in the bank: 787M vs. IMTX (431M). IMTX has less debt than IDYA: IMTX (16.4M) vs IDYA (27.2M). IDYA has higher revenues than IMTX: IDYA (215M) vs IMTX (84.8M).
IDYAIMTXIDYA / IMTX
Capitalization3.25B1.32B246%
EBITDA-204.84M-106.34M193%
Gain YTD7.116-6.381-112%
P/E RatioN/A27.61-
Revenue215M84.8M254%
Total Cash787M431M183%
Total Debt27.2M16.4M166%
FUNDAMENTALS RATINGS
IDYA vs IMTX: Fundamental Ratings
IDYA
IMTX
OUTLOOK RATING
1..100
2159
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
75
Overvalued
PROFIT vs RISK RATING
1..100
57100
SMR RATING
1..100
9496
PRICE GROWTH RATING
1..100
4047
P/E GROWTH RATING
1..100
10066
SEASONALITY SCORE
1..100
5036

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IDYA's Valuation (27) in the null industry is somewhat better than the same rating for IMTX (75). This means that IDYA’s stock grew somewhat faster than IMTX’s over the last 12 months.

IDYA's Profit vs Risk Rating (57) in the null industry is somewhat better than the same rating for IMTX (100). This means that IDYA’s stock grew somewhat faster than IMTX’s over the last 12 months.

IDYA's SMR Rating (94) in the null industry is in the same range as IMTX (96). This means that IDYA’s stock grew similarly to IMTX’s over the last 12 months.

IDYA's Price Growth Rating (40) in the null industry is in the same range as IMTX (47). This means that IDYA’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's P/E Growth Rating (66) in the null industry is somewhat better than the same rating for IDYA (100). This means that IMTX’s stock grew somewhat faster than IDYA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDYAIMTX
RSI
ODDS (%)
Bearish Trend 2 days ago
65%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signal:
Gain/Loss:
IMTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NILIX15.740.05
+0.32%
Neuberger International Sel I
FMCAX45.27N/A
N/A
Fidelity Advisor Stock Selec Mid Cp M
FCICX17.89-0.05
-0.28%
NYLI PineStone International Equity Cl C
OGLCX64.89-0.83
-1.26%
Invesco Global C
CTOGX17.74-0.26
-1.44%
Calamos Timpani SMID Growth R6

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with NUVL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+5.53%
NUVL - IDYA
59%
Loosely correlated
+6.59%
XNCR - IDYA
58%
Loosely correlated
+3.66%
XENE - IDYA
57%
Loosely correlated
+3.02%
DYN - IDYA
55%
Loosely correlated
+2.41%
VIR - IDYA
55%
Loosely correlated
+8.08%
More

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with IDYA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+4.80%
IDYA - IMTX
54%
Loosely correlated
+5.53%
XNCR - IMTX
49%
Loosely correlated
+3.66%
VYGR - IMTX
49%
Loosely correlated
+2.74%
VIR - IMTX
49%
Loosely correlated
+8.08%
KURA - IMTX
49%
Loosely correlated
+1.63%
More